Vaccination against pneumococcal infection in patients with chronic kidney disease
https://doi.org/10.22627/2072-8107-2020-19-3-19-25
Abstract
The review discusses the current state of the use of vaccine prevention in the debarment of pneumococcal infection in patients with chronic kidney disease (CKD). Clinical and immunological features of various groups of patients with chronic kidney disease are considered, the specifics of their immunoreactivity, the features of their immune system, due to the underlying and concomitant diseases, as well as treatment. The review analyzes data on various approaches to preventive vaccination and discusses the results of various vaccination regimens and vaccines.
Based on the materials reviewed, recommendations are given for organizing the most rational vaccine prevention of pneumococcal infection in patients with chronic kidney disease.
About the Authors
A. A. Tarasova
Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Alla Tarasova - MD, professor.
Nizhny Novgorod
K. V. Mashilov
I.I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Kirill Mashilov - Associate Professor, PhD.
Moscow
V. B. Polishchuk
I.I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Valentina Polishchuk – PhD.
Moscow
A. A. Ryzhov
I.I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Aleksey Ryzhov – PhD.
Moscow
References
1. New in the clinic, diagnosis and vaccination of controlled infections. Ed. M.P. Kostinov. M., 1997:1 10. (in Russ.)
2. Clinical Practice Guidelines 2012 KDIGO for the diagnosis and treatment of chronic kidney disease. Nephrology and Dialysis. 2017.1 (19): 22—206. (In Russ.) DOI: 10.28996/1680-4422-2017-1-22-206.
3. Clinical and immunological effectiveness of immunobiological preparations: Handbook. Ed. M.P. Kostinov, N.A. Ozeretskovsky. М., 2004: 256. (in Russ.)
4. Chronic kidney disease. Clinical recommendations. Adopted at the IV Congress of Primary Care Physicians of the South of Russiania, IX Konferencii vrachej obshchej praktiki (semejnyh vrachej) YUga Rossii 7 noyabrya 2014 g., g. Rostov-na-Donu = IX Conference of General Practitioners (Family Doctors) of the South of Russiania on November 7, 2014, Rostov-on-Don. Moscow—Kazan—Rostov-on-Don; 2014. (In Russ.)
5. Guidelines for vaccination in patients with chronic kidney disease. Indian J Nephrol. 2016; Apr; 26(Suppl 1): 15—8.
6. Levey A.S., Stevens L.A., Schmid C.H. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009; 150: 604—12.
7. Kostinov M.P., Tarasova A.A. Recommendations for vaccinating children with chronic kidney disease. Epidemiologiya i Vakcinopro-filaktika=Epidemiology and Vaccination. 2014; 4 (77): 89—91. (In Russ.)
8. Shahinian V.B., Hedgeman E., Gillespie B.W. CDC CKD Surveillance System. Estimating prevalence of CKD stages 3—5 using health system data. Am. J. Kidney Dis. 2013; 61: 930—8.
9. Vandecasteele S.J., Ombelet S., Blumental S., Peetermans WE. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J. 2015;Jun; 8(3):318—24.
10. Dobronravov V.A., Smirnov A.V., Dragunov S.V. Epidemiology of chronic renal failure in the Northwest region of Russiania: on the way to creating a register of chronic renal disease. Ter. Arh.=Therapeutic Archive, 2004; 76(9): 57—61. (In Russ.)
11. Ryzhov A.A., Kostinov M.P., Magarshak O.O. The use of vaccines against pneumococcal and hemophilic type b infections in people with chronic pathology. Epidemiologiya i Vakcinoprofilaktika=Epi-demiology and Vaccination. 2004; 6(19): 24—27. (In Russ.)
12. Smirnov A.V, Kayukov I.G., Yesayan A.M. A preventive approach in modern nephrology. Nefrologiya=Nephrology, 2004; 8(3): 7— 14. (In Russ.)
13. Kostinov M.P., Maleev V.V. Hib infection: vaccine prevention issues. M .: Medicine for everyone, 1998: 78. (in Rus.)
14. Bikbov B.T., Tomilina N.A. The contingent and treatment quality indicators in patients on replacement therapy of end stage renal disease in the Russian Federation in 1998—2013 years. Nefrologiya i Dializ=Nephrology and Dialysis. 2016; 2(18): 98—164. (In Rus.)
15. Shavyrin A.A., Kostinov M.P., Magarshak O.O. Ryzhov A.A., Seu L.N. The use of pneumococcal vaccine in patients with renal pathology. Zhurnal Мikrobiologii, Еpidemiologii i Immunologii=Journal of Microbiology, Epidemiology and Immunology 2001; 5:72—74. (in Russ.)
16. U.S. Renal Data System. USRDR 2004 Annual Data Report, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2004.
17. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol, 2001; 12: 2753—2758.
18. de Portu S, Citarella A, Cammarota S, Menditto E, Mantovani LG. Pharmaco-Economic Consequences of Losartan Therapy in Patients Undergoing Diabetic End Stage Renal Disease in EU and USA. Clin Exp Hypertens, 2011; 33(3):174—178.
19. Neovius M., Jacobson S.H., Eriksson J.K. et al. Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study. BMJ Open. 2014; 4:e004251. doi: 10.1136/bmjopen-2013-004251.
20. Ortiz A., Covic A., Fliser D. et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014; 383: (9931):1831—43. doi: 10.1016/S0140-6736(14)60384-6.
21. Dlin V.V., Osmanov I.M., Chugunova O.L. Infektsiia mochevoi siste-my u detei: Rukovodstvo dlia vrachei =Urinary Infection in Children: A Guide for Physicians. red. VV Dlin, I.M. Osmanov, O.L. Chugunovа (sost. S.L. Morozov). 2-e izd., dop. M.: Overlei, 2017:422. (In Russ.)
22. Atlas of Chronic Kidney Disease in the United States. Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. 2010. American Journal of Kidney Diseases. 2009; 53(1 ):S1 —S5. Doi: 10.1053/j.ajkd.2008.11.003.
23. Bikbov B.T., Tomilina N.A Renal replacement therapy for ESRD in Russianian Federation, 1998-2013 Report of the Russian Renal Replacement Therapy Registry. Part 1. Nefrologiya i Dializ=Neph-rology and Dialysis. 2015; S3: 5-111. (In Rus.).
24. van Dijk P.C., Jager KJ., de Charro F et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERAEDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001; 16:1120-9. DOI: 10.1093/ndt/16.6.1120.
25. Guo H., Liu J., Collins AJ. et al. Pneumonia in incident dialysis patients — the United States Renal Data System Nephrol. Dial Transplant. 2008; 23:680—6. DOI: 10.1093/ndt/gfm474.
26. Sarnak M.J., Jaber B.L. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001; 120:1 883—7. DOI: 10.1378/chest.120.6.1883.
27. Vandecasteele S.J., Kurella T.M. A patient-centered vision of care for ESRD: dialysis as a bridging treatment or as a final destination? J Am Soc Nephrol. 2014; 25:1647—51. DOI: 10.1681/ASN.2013101082.
28. Sokurenko, A.N. Fedoseev T.V. Borisova Immunological disorders in patients with chronic kidney disease. Prospects for immune replacement therapy. Klinicheskaya Рraktika=Clinical Practice, 2014; 3: 83-88 (In Russ.)
29. Kostinov M.P., Magarshak O.O., Sergeeva T.A. Modern approach to the immunoprophylaxis of infections in patients with kidney diseases. Nefrologiya i Dializ= Nephrology and Dialysis. 2001; 1(3): 24-28. (in Russ.)
30. Tarasova A.A., Lukushkina E.F, Kostinov M.P. Vaccine prophylaxis: educational-methodical manual. N. Novgorod, 2018:108. (In Russ.)
31. Chuchalin A.G., Bilichenko T.I., Osipova G.L. Vaccine prophylaxis of respiratory diseases as part of primary health care to the population. Clinical recommendations. Pul'monologiya=Pulmonology. 2015; 2 (S. 25): 1-19 (In Russ.)
32. Wiedermann U., Sitte H.H., Burgmann H. et al. Impfungen bei Im-mundefekten/Immunsuppression - Expertenstatement und Empfeh-lungen. Wien klin Wochenschrift. 2016;128(4): 337-76. doi: 10.1007/s00508-016-1033-6.
33. Grindt M., Sester M., Sester U. et al. Molecular aspects of T- and B-cell function in uremia. Kidney Int. 2001; 59 (Suppl 78): S206-11. DOI: 10.1046/j.1523-1755.2001.59780206.x.
34. Kim K.W., Chung B.H., Jeon EJ. et al. B cell-associated immune profiles in patients with endstage renal disease (ESRD)/ Exp Mol Med. 2012; 44:465-72. doi: 10.3858/emm.2012.44.8.053.
35. Bond T.C., Spaulding A.C., Krisher J., McClellan W. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J of kidney Dis. 2012; 60(6):959-65. doi: 10.1053/j.ajkd.2012.04.018.
36. Bond; McGrath L.J., Kshirsagar A.V. Influenza and pneumococcal vaccination in dialysis patients: merely a shot in the arm. Am J Kidney Dis. 2012; 60(6):890-2. DOI: 10.1053/j.ajkd.2012.09.001.
37. Kausz A.T., Guo H., Pereira B.J. et al. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol. 2005; 16:3092-101. DOI: 10.1681/ASN.2004110910.
38. Goldstein S.L. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif. 2012; 33:1 31 -7. doi: 10.1159/000334143.
39. Grzegorzewska А.Е. Prophylactic vaccinations in chronic kidney disease: Current status. Human Vaccines & Immunotherapeutics. 2011; 11:2599-605. doi: 10.1080/21645515.2015.1034915.
40. McDonald H.I., Thomas S.L., Millett E.R.C., Quint J., Nitsch D. Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records. BMJ Open Diabetes Res Care. 2017; 5(1): e000332. doi: 10.1136/bmjdrc-2016-000332.eCollection 2017.
41. Rahier J., Magro F, Abreu C., Armuzzi A., Ben-Horin S., Chowers Y, Cottone M., de Ridder L., Doherty G., Ehehalt R., Esteve M., Katsa-nos K., Lees C.W., Macmahon E., Moreels T., Reinisch W., Tilg H., Tremblay L., Veereman-Wauters G., Viget N., Yazdanpanah Y., Eliakim R., Colombel J.F European Crohn's and Colitis Organisation (ECCO). European Crohn's and Colitis Organisation (ECCO). Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014; 8(6):443-68. DOI: 10.1016/j.crohns.2013.12.013
42. Centers for Disease Control and Prevention (CDC). Use of 1 3-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012; 61(40):816-9.
43. Rubin L.G., Levin MJ., Ljungman P., Davies E.G., Avery R., Tomblyn M., Bousvaros A., Dhanireddy S., Sung L., Keyserling H., Kang I.; Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of theimmunocompromised host. Clin. Infect. Dis. 2014; 58(3):e44-100. doi: 10.1093/cid/cit816.
44. Radhakrishnan J., Cattran D.C. The KDIGO practice guideline on glomerulonephritis: reading between the (guide) lines-application to the individual patient. Kidney Int. 2012; 82(8):840-56. DOI: 10.1038/ki.2012.280.
45. Farhat F, Wortmann G. Vaccinating adults who are pregnant, older, or immunocompromised, or have chronic kidney disease. Cleveland Clinic J of medicine. 2015; 2 (6): 341-7. doi: 10.3949/ccjm.82a.14075.
46. Garcia-Rojas A., Perez-Trallero E., Gil-Gregorio P., de la Camara R., Morató M.L., Rodriguez A., Barberan J., Dominguez-Hernandez V, Linares-Rufo M., Jimeno-Sanz I., Sanz-Herrero F, Espinosa-Arranz J., Garcia-Sanchez V, Galindo-Izquierdo M., Martinez-Castelao A. Recommendations for vaccination against pneumococcus in patients with kidney diseases in Spain. Nefrologia. 2014; 34(5): 545-51. doi: 10.3265/Nefrologia.pre2014.May. 12534.
47. Guidelines for Clinical Immunology in Respiratory Medicine. 1st ed. M.P. Kostinov, A.G. Chuchalin, ed. M.: ATMO LLC, 2016: 128. (In Russ.)
48. Zverev V.V., Kostinov M.P., Cherdantsev A.P. et al. Vaccination of pregnant women against influenza: Federal clinical guidelines. N. Novgorod, 2015: 42. (In Russ.)
49. Kostinov M.P. Vaccination of children with impaired health: A practical guide for doctors. 1st ed. M .: Medicine for all, 1996: 78. (In Russ.)
50. Gilbertson D.T., Guo H., Arneson T.J., Collins A.J. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrol Dial Transplant. 2011; 26(9): 2934— 9. doi: 10.1093/ndt/gfq853.
51. Slinin Y., Foley R.N., Collins AJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int. 2006; 70(6):1135—41. DOI: 10.1038/sj.ki.5001714.
52. Kostinov M.P., Tarasova A.A. Vaccination of children with chronic kidney disease. Epidemiologiya i Vakcinoprofilaktika=Epidemiolo-gy and Vaccination. 2014; 2(74): 101 — 102. (In Russ.)
53. Vaccination of children with kidney disease: a manual for doctors. Ed. M.P. Kostinov. M.: MWD, 2012: 96. (In Russ.).
54. Guidelines for Clinical Immunology in Respiratory Medicine. 2-nd ed. M.P. Kostinov, A.G. Chuchalin, ed. M.: MDV Group, 2018: 304 (In Russ.)
55. Kostinov M.P. , Rusnak FI. Vaccination in childrens with renal disease. Nefrologiya=Nephrology 2016; 1(20): 24—35. (in Russ.)
56. Citation Mitra S., Stein G.E., Bhupalam S., Havlichek D.H. Immuno-genicity of 13-valent conjugate pneumococcal vaccine in patients 50 years and older with endstage renal disease and on dialysis. Clin Vaccine Immunol. 2016; 23:884—7. DOI: 10.1128/CVI.00153—16.
57. Tobudic S., Plunger V, Sunder-Plassmann G., Riegersperger M., Burgmann H. Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients. PLoS One. 2012; 7(9):e46133.
58. Immunocorrection in Pediatrics: A Practical Guide for Physicians. Ed. M.P. Kostinov. M., 1997: 111. (In Russ.)
59. Immunomodulators and vaccination: a Guide. Ed. M.P. Kostinov, I.L. Solovieva. M., 2013:272. (In Russ.)
60. Solovieva I.L., Kostinov M.P., Kuselman A.I. Features of the vaccination of children with altered premorbid background against hepatitis B, measles, mumps. Ulyanovsk, 2006:296. (In Russ.)
61. I.L. Solovievа, M.P. Kostinov, A.I. Kuselman, E.I. Mikawa. A method of vaccination against hepatitis B in children with reduced immu-noreactivity. RF patent for the invention No. 2294213 of 02.27.2007. (In Russ.)
62. Immunomodulation in vaccination of patients with COPD. LAP LAMBERT Academic Publishing RU, 201 8: 92. (In Russ.)
63. Kostinov M.P., Tarasova A.A. Vaccine prophylaxis of pneumococcal infection and influenza in autoimmune diseases. M., 2009: 252. (In Russ.)
64. Vaccination against hepatitis B, influenza and rubella in adult patients with chronic diseases. Practical Guide: M.P. Kostinov, V.V. Zverev, ed. M.: Medicine for all, 2009:1 96. (In Russ.)
65. New in the clinic, diagnosis and vaccination of controlled infections. Ed. M.P. Kostinov. M., 1997:1 10. (in Russ.)
66. Clinical and immunological effectiveness of immunobiological preparations: Handbook. Ed. M.P. Kostinov, N.A. Ozeretskovsky. М., 2004: 256. (in Russ.)
67. Guidelines for vaccination in patients with chronic kidney disease. Indian J Nephrol. 2016; Apr; 26(Suppl 1): 15—8.
68. Kostinov M.P., Tarasova A.A. Recommendations for vaccinating children with chronic kidney disease. Epidemiologiya i Vakcinopro-filaktika=Epidemiology and Vaccination. 2014; 4 (77): 89—91. (In Russ.)
69. Vandecasteele S.J., Ombelet S., Blumental S., Peetermans WE. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J. 2015;Jun; 8(3):318—24.
70. Ryzhov A.A., Kostinov M.P., Magarshak O.O. The use of vaccines against pneumococcal and hemophilic type b infections in people with chronic pathology. Epidemiologiya i Vakcinoprofilaktika=Epi-demiology and Vaccination. 2004; 6(19): 24—27. (In Russ.)
71. Kostinov M.P., Maleev V.V. Hib infection: vaccine prevention issues. M .: Medicine for everyone, 1998: 78. (in Rus.)
72. Shavyrin A.A., Kostinov M.P., Magarshak O.O. Ryzhov A.A., Seu L.N. The use of pneumococcal vaccine in patients with renal pathology. Zhurnal Мikrobiologii, Еpidemiologii i Immunologii=Journal of Microbiology, Epidemiology and Immunology 2001; 5:72—74. (in Russ.)
Review
For citations:
Tarasova A.A., Mashilov K.V., Polishchuk V.B., Ryzhov A.A. Vaccination against pneumococcal infection in patients with chronic kidney disease. CHILDREN INFECTIONS. 2020;19(3):19-25. (In Russ.) https://doi.org/10.22627/2072-8107-2020-19-3-19-25
Views:
10065
Email this article 